Psyence Biomedical Statistics
Total Valuation
PBM has a market cap or net worth of $11.33 million. The enterprise value is -$9.74 million.
Important Dates
The next estimated earnings date is Friday, December 4, 2026, before market open.
| Earnings Date | Dec 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PBM has 3.81 million shares outstanding. The number of shares has increased by 1,688.07% in one year.
| Current Share Class | 3.81M |
| Shares Outstanding | 3.81M |
| Shares Change (YoY) | +1,688.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.68% |
| Owned by Institutions (%) | 13.74% |
| Float | 1.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.35 |
| P/TBV Ratio | 0.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 30.00, with zero debt.
| Current Ratio | 30.00 |
| Quick Ratio | 29.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -665.22 |
Financial Efficiency
Return on equity (ROE) is -31.31% and return on invested capital (ROIC) is -17.92%.
| Return on Equity (ROE) | -31.31% |
| Return on Assets (ROA) | -31.33% |
| Return on Invested Capital (ROIC) | -17.92% |
| Return on Capital Employed (ROCE) | -19.64% |
| Weighted Average Cost of Capital (WACC) | 13.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$573,396 |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.97% in the last 52 weeks. The beta is 1.73, so PBM's price volatility has been higher than the market average.
| Beta (5Y) | 1.73 |
| 52-Week Price Change | -82.97% |
| 50-Day Moving Average | 4.37 |
| 200-Day Moving Average | 3.90 |
| Relative Strength Index (RSI) | 41.30 |
| Average Volume (20 Days) | 58,069 |
Short Selling Information
The latest short interest is 19,062, so 0.50% of the outstanding shares have been sold short.
| Short Interest | 19,062 |
| Short Previous Month | 20,292 |
| Short % of Shares Out | 0.50% |
| Short % of Float | 1.72% |
| Short Ratio (days to cover) | 0.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.30M |
| Pretax Income | -6.88M |
| Net Income | -6.88M |
| EBITDA | -6.30M |
| EBIT | -6.30M |
| Earnings Per Share (EPS) | -$2.99 |
Full Income Statement Balance Sheet
The company has $21.07 million in cash and no debt, with a net cash position of $21.07 million or $5.52 per share.
| Cash & Cash Equivalents | 21.07M |
| Total Debt | n/a |
| Net Cash | 21.07M |
| Net Cash Per Share | $5.52 |
| Equity (Book Value) | 32.08M |
| Book Value Per Share | 8.41 |
| Working Capital | 20.84M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$8.14 million and capital expenditures -$229, giving a free cash flow of -$8.14 million.
| Operating Cash Flow | -8.14M |
| Capital Expenditures | -229 |
| Depreciation & Amortization | 5,266 |
| Net Borrowing | n/a |
| Free Cash Flow | -8.14M |
| FCF Per Share | -$2.13 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PBM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1,688.07% |
| Shareholder Yield | -1,688.07% |
| Earnings Yield | -100.74% |
| FCF Yield | -71.88% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on February 2, 2026. It was a reverse split with a ratio of 1:6.25.
| Last Split Date | Feb 2, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:6.25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |